Kymera Therapeutics (KYMR) Q4 2025 Earnings

4NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.95
-0.89
-0.83
-0.77

Details

Expected EPS
-0.769746
Actual EPS
-0.94
Surprise EPS
-0.17
Surprise Percent
+22.12%

Description

Kymera Therapeutics (KYMR) has reported earnings of -0.94 per share for Q4 2025.

0 Comments

Share your thoughts